By vgreene, 18 November, 2020 A positive influenza test result does not preclude SARS CoV 2 infxn For hospitalized pts w a positive influenza test result start antiviral tx of influenza w oseltamivir ASAP follow guidelines for dx and tx of CAP and other resp infxns incl SARS CoV 2 if
By vgreene, 18 November, 2020 Co infxn w influenza A or B and SARS CoV 2 can occur and should be considered particularly in hospitalized pts severe resp dz
By vgreene, 18 November, 2020 Co infxn w influenza A or B and SARS CoV 2 can occur and should be considered particularly in hospitalized pts severe resp dz
By vgreene, 18 November, 2020 Influenza and COVID 19 have overlapping s sx Testing can help distinguish between the two but don t wait for results before initiating empiric antiviral tx for influenza in above priority groups
By vgreene, 18 November, 2020 During periods of co circulation of influenza and SARS CoV 2 treat the following groups empirically for influenza 1 hospitalized pts w resp illness 2 outpts w severe complicated or progressive resp illness and 3 outpts at higher risk for influenza complic
By vgreene, 17 November, 2020 Medicago GlaxoSmithKline unnamed NCT04636697 virus like particle given as 2 doses plant based combined w adjuvants
By vgreene, 17 November, 2020 virus like particle vaccines self assembling multiprotein structures mimicking authentic native virus but lacking viral genome nonreplicative nonpathogenic
By vgreene, 17 November, 2020 Fluvoxamine vs Placebo and Clinical Deterioration in Out Patients With Symptomatic COVID 19 A Randomized Clinical Trial access full text JAMA article
